Cyanide Bridged Platinum-Iron Complexes as Cisplatin Prodrug Systems: Design and Computational Study

The potential role of cyanide-bridged platinum-iron complexes as an anti-cancer Pt(IV) prodrug is studied. We present design principles of a dual-function prodrug that can upon reduction dissociate and release concurrently six cisplatin units and a ferricyanide anion per prodrug unit. The prodrug molecule is a unique complex of hepta metal centers consisting of a ferricyanide core with six Pt(IV) centers each bonded to the Fe(III) core through a cyano ligand. The functionality of the prodrug is addressed through density functional theory (DFT) calculations.     

Selective Photocatalytic Oxidation of Sulfides in Lanthanide Metal -Organic Frameworks Incorporating Ru(2,2′-bpy)3 photosensitizer

Three isostructural lanthanide metal-organic frameworks (Ln-MOFs) were synthesized with uncoordinated N^N site, and the Ru(N^N)₃ photosensitizer was introduced via coordination link. These functionalized frameworks showed excellent performance in the photocatalytic oxidation of sulfides with good conversion and high sulfoxide selectivity.     

The Stationary Optomechanical Entanglement Between an Optical Cavity Field and a Cubic Anharmonic Oscillator

International Journal of Theoretical Physics - Currently, the creation of the quantum entanglement is still one of the most challenging goals. Here, we theoretically investigate the stationary...     

Inherent mass transfer engineering of a Co,N co-doped carbon material towards oxygen reduction reaction

Oxygen reduction reaction (ORR) is an important process for the conversion and utilization of a wide range of renewable energy sources, and is critical for the ...     

SYNTHESIS,CHARACTERIZATION, CRYSTAL STRUCTURE,AND DFT STUDY OF N-(2-METHOXY-5- (4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) PYRIDIN-3-YL)CYCLOPROPANESULFONAMIDE

Journal of Structural Chemistry - N-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)cyclopropanesulfonamide is an organic intermediate with borate and sulfonamide groups,...     

Tributylstibine-mediated olefination of carbonyl compounds with bromomalonic ester and with dibromomalonic ester—A possible pathway through a stibonium ylide via halophilic initiation by tertiary stibines

Tributylstibine can mediate the olefination of carbonyl compounds with bromomalonic ester and with dibromomalonic ester. An initial halophilic attack of tributylstibine on the bromine of bromomalonic or dibromomalonic ester forming an ion pair of bromotributylstibonium cation and malonic (A) or bromomalonic ester carbanion (B) , respectively, is proposed. These ion pairs react with carbonyl compounds to achieve subsequent olefination. Alternatively, 2 equiv of A collapse, with elimination of malonic ester, to form stiborane D , and the ion pair B reacts with another equivalent of tributylstibine to form stiborane D. This last undergoes a Wittig-type reaction with carbonyl compound to achieve olefination.     

On resin synthesis of sulfated oligosaccharides

Sulfated glycans are involved in many biological processes, making well-defined sulfated oligosaccharides highly sought molecular probes. These compounds are a considerable synthetic challenge, with each oligosaccharide target requiring specific synthetic protocols and extensive purifications steps. Here, we describe a general on resin approach that simplifies the synthesis of sulfated glycans. The oligosaccharide backbone, obtained by Automated Glycan Assembly (AGA), is subjected to regioselective sulfation and hydrolysis of protecting groups. The protocol is compatible with several monosaccharides and allows for multi-sulfation of linear and branched glycans. Seven diverse, biologically relevant sulfated glycans were prepared in good to excellent overall yield.

Well-defined sulfated oligosaccharides are important synthetic targets. We present an on resin approach for the synthesis of sulfated glycans with a broad reaction scope that overcomes previous limitations associated with on resin synthesis.     

Competition of spiral waves in heterogeneous CGLE systems

Nonlinear Dynamics - The effects of spatial heterogeneity on a two-dimensional complex Ginzburg–Landau equation model are studied. In general, the interaction of a pair of spiral waves with a...     

The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics

With the widespread clinical use of drug combinations, the incidence of drug–drug interactions (DDI) has significantly increased, accompanied by a variety of adverse reactions. Drug transporters play an important role in the development of DDI by affecting the elimination process of drugs in vivo, especially in the pathological state. Tubulointerstitial fibrosis (TIF) is an inevitable pathway in the progression of chronic kidney disease (CKD) to end-stage renal disease. Here, the dynamic expression changes of eleven drug transporters in TIF kidney have been systematically investigated. Among them, the mRNA expressions of Oat1, Oat2, Oct1, Oct2, Oatp4C1 and Mate1 were down-regulated, while Oat3, Mrp2, Mrp4, Mdr1-α, Bcrp were up-regulated. Pearson correlation analysis was used to analyze the correlation between transporters and Creatinine (Cr), OCT2 and MATE1 showed a strong negative correlation with Cr. In contrast, Mdr1-α exhibited a strong positive correlation with Cr. In addition, the pharmacokinetics of cimetidine, ganciclovir, and digoxin, which were the classical substrates for OCT2, MATE1 and P-glycoprotein (P-gp), respectively, have been studied. These results reveal that changes in serum creatinine can indicate changes in drug transporters in the kidney, and thus affect the pharmacokinetics of its substrates, providing useful information for clinical use.     

Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary

Viral infections pose a persistent threat to human health. The relentless epidemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global health problem, with millions of infections and fatalities so far. Traditional approaches such as random screening and optimization of lead compounds by organic synthesis have become extremely resource- and time-consuming. Various modern innovative methods or integrated paradigms are now being applied to drug discovery for significant resistance in order to simplify the drug process. This review provides an overview of newly emerging antiviral strategies, including proteolysis targeting chimera (PROTAC), ribonuclease targeting chimera (RIBOTAC), targeted covalent inhibitors, topology-matching design and antiviral drug delivery system. This article is dedicated to Prof. Dr. Erik De Clercq, an internationally renowned expert in the antiviral drug research field, on the occasion of his 80th anniversary.